About Contact Us Careers

Transcriptomics Market Trends

Request Free Sample Copy

Report ID: 3935
Published Date: Aug 21, 2024
Report Format: PDF, PPT

Buy Now

Transcriptomics Market Trends

Growth Drivers

Increasing Prevalence of Cancer
Increasing Demand for Personalized Medicines
Growing Investment in the R&D Activities

Challenges

Lack of Skilled Professionals
Few Drawbacks of RNA Sequencing

Transcriptomics Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	7.3%
Base Year Market Size (2023)	USD 7.04 billion
Forecast Year Market Size (2036)	USD 17.59 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Transcriptomics Market Size, Growth Report 2036

Author Credits: Radhika Pawar

Report ID: 3935
Published Date: Aug 21, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of transcriptomics is estimated at USD 7.45 billion.

Transcriptomics Market size was valued at USD 7.04 billion in 2023 and is poised to cross USD 17.59 billion by 2036, expanding at more than 7.3% CAGR during the forecast period i.e., between 2024-2036. Increasing personalized approach towards treatment of rare diseases will boost the market growth.

Asia Pacific industry is likely to hold largest revenue share by 2036, on the back of rising healthcare expenditure across the region.

The major players in the market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., CD Genomics, F. Hoffmann-La Roche AG, GenXPro GmbH, Qiagen N.V., Illumina, Inc., The Merck Group, Siemens AG, and others.

Inquiry Before Buying Request Free Sample